Differences in the incidence of lurasidone adverse events between depressive disorders and schizophrenia in double-blind, randomized, placebo-controlled trials: a meta-analysis.
Taro KishiHiroshi NakamuraNakao IwataPublished in: Psychopharmacology (2021)
The incidence of AEs did not differ between schizophrenia and depressive disorders.